Klinomics Invests 1 Billion KRW to Establish Bioventure Corporation
[Asia Economy Reporter Minwoo Lee] Clinomics announced on the 29th that it has invested 1 billion KRW in cash to establish the bio venture company Zeromix. With this, Clinomics will secure a 50% stake in Zeromix.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Looks Even More Like Him in Person": Albino Water Buffalo with Golden Hair and Pink Skin Nicknamed 'Trump'
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Clinomics stated, "We have established a venture company for anticancer drug development and drug repositioning business," adding, "The purpose is to create synergy for new business entry and to participate in management."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
